Examining the feasibility of clinical grade CD271+ enrichment of mesenchymal stromal cells for bone regeneration

Current clinical trials utilize mesenchymal stromal cells (MSCs) expanded in culture, however these interventions carry considerable costs and concerns pertaining to culture-induced losses of potency. This study assessed the feasibility of new clinical-grade technology to obtain uncultured MSC isola...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:PloS one 2015-03, Vol.10 (3), p.e0117855-e0117855
Hauptverfasser: Cuthbert, Richard J, Giannoudis, Peter V, Wang, Xiao N, Nicholson, Lindsay, Pawson, David, Lubenko, Anatole, Tan, Hiang B, Dickinson, Anne, McGonagle, Dennis, Jones, Elena
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!